Resiquimod [144875-48-9]
R183731
Estimated Purity≥98%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameResiquimod [144875-48-9]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥98%
- FormatSoluble in DMSO (100 mM), ethanol (50 mM), 100% or 5% methanol, and dichloromethane. Insoluble in water.
- Scientific DescriptionToll-like receptor 7/8 agonist; R-848, R848, S28463, alpha-dimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol.
- Storage Instruction-20°C
- UNSPSC12352200
References
- Rook AH, Gelfand JM, Wysocka M, et al. Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma. Blood. 2015 Sep 17;126(12):1452-1461. PMID: 26228486. Craft N, Birnbaum R, Quanquin N, et al. Topical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice. Clin Vaccine Immunol. 2014 Sep;21(9):1314-1322. PMID: 25030052. Wang YY, Liu S, Lian F, et al. Toll-like receptor 7/8 agonist resiquimod induces late preconditioning in neonatal cardiac myocytes. Acta Pharmacol Sin. 2011 May;32(5):565-572. PMID: 21516132.